Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Home > Insider Trading > Filing (0000899243-20-004418)

Filing Details

Accession Number:: 0000899243-20-004418
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-12 21:33:56
Reporting Period:: 2020-02-11

Accepted Time:: 2020-02-12 21:33:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1615219	Salarius Pharmaceuticals Inc.	SLRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1233253	C Arnold Hanish	C/o Salarius Pharmaceuticals, Inc. 2450 Holcombe Blvd., Suite J - 608 Houston TX 77021		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-02-11	4,350	$1.15	7,350	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct